Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 DNA Way
South San Francisco, CA 94080
Summary
- At Genentech Roche, I oversee and direct the pipeline throughout development stages as the franchise head of gastroenterology
Education & Training
- Stanford UniversityM.Sc., Health Services Research, 2009 - 2011
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Gastroenterology, 2008 - 2011
- Stanford UniversityMS, Health Services & Policy Research, 2010
- University of Tennessee Health Science Center College of MedicineClass of 2005
- Duke UniversityB.A., Chemistry, Biochemistry, Honors, 1996 - 2000
Publications & Presentations
PubMed
- 5 citationsMental Health Service Needs in Children and Adolescents With Inflammatory Bowel Disease and Other Chronic Gastrointestinal Disorders.Jessie J. Wong, Michele H Maddux, K.T. Park
Journal of Pediatric Gastroenterology and Nutrition. 2018-09-01 - 49 citationsHealth outcomes in US children with abdominal pain at major emergency departments associated with race and socioeconomic status.Louise Wang, Corinna Haberland, Cary Thurm, Jay Bhattacharya, K.T. Park
Plos One. 2015-08-12 - 69 citationsEffectiveness and Cost-effectiveness of Measuring Fecal Calprotectin in Diagnosis of Inflammatory Bowel Disease in Adults and ChildrenZhuo Yang, Nick Clark, K.T. Park
Clinical Gastroenterology and Hepatology. 2014-02-01
Journal Articles
- Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn’s & Colitis Foundation: Charting the Future of Pediatric IBDJoel R Rosh, Athos Bousvaros, Laurie S Conklin, Caren A Heller, David Ziring, K T Park, Subra Kugathasan, Michael D Kappelman, Andrew B Grossman, Jeffrey S Hyams, Lee ..., Inflammatory Bowel Diseases
- Treatment of CGD-Associated Colitis with the IL-23 Blocker UstekinumabK T Park, Manish J Butte, Journal of Clinical Immunology
- Effectiveness and Cost-Effectiveness of Measuring Fecal Calprotectin in Diagnosis of Inflammatory Bowel DiseaseYang Z, Clark N, Park K, Clin Gastroenterol Hepatol, 7/21/2013
- Join now to see all
Grant Support
- National Institutes of HealthNIDDK2012–Present
Research History
- See Institutional Profile Linkhttps://med.stanford.edu/profiles/kun-park
Professional Memberships
- Member
- Crohn's & Colitis Foundation of AmericaMember
- Member
Industry Relationships
- See Disclosures/Collaborations at Institutional Profile Link, various
External Links
- Stanford Profilehttp://med.stanford.edu/profiles/Kun_Park/
- Professional Twitterhttps://twitter.com/KTPark6
- LinkedInhttps://www.linkedin.com/nhome/?trk=
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: